LY-344864 is an experimental drug of the triptan and tetrahydrocarbazolamine families with a tricyclic cyclized tryptamine structure which acts as an agonist for the 5-HT1F serotonin receptor. It has antimigraine activity in animal models but was never developed for this indication as a medicine, however it continues to be used in scientific research and in recent years has been investigated as a potential agent for stimulating mitochondrial biogenesis, which can facilitate repair to damaged cells and tissues with a number of potential medical applications.
See also Tetrahydrocarbazolamine Cyclized tryptamine Frovatriptan
References